Tavio Capital LLC acquired a new position in Davita Inc (NYSE:DVA) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 206,338 shares of the company’s stock, valued at approximately $11,609,000. Davita comprises approximately 4.7% of Tavio Capital LLC’s portfolio, making the stock its 10th largest position.
Several other institutional investors also recently made changes to their positions in the company. HighTower Advisors LLC grew its stake in shares of Davita by 768.1% in the second quarter. HighTower Advisors LLC now owns 39,488 shares of the company’s stock worth $2,224,000 after acquiring an additional 34,939 shares during the last quarter. Scotia Capital Inc. grew its stake in shares of Davita by 5.2% in the second quarter. Scotia Capital Inc. now owns 30,206 shares of the company’s stock worth $1,699,000 after acquiring an additional 1,494 shares during the last quarter. APG Asset Management N.V. boosted its stake in Davita by 20.3% during the second quarter. APG Asset Management N.V. now owns 59,908 shares of the company’s stock worth $2,960,000 after buying an additional 10,100 shares in the last quarter. Pictet Asset Management Ltd. boosted its stake in Davita by 3,290.3% during the second quarter. Pictet Asset Management Ltd. now owns 1,132,521 shares of the company’s stock worth $63,716,000 after buying an additional 1,168,020 shares in the last quarter. Finally, Meadow Creek Investment Management LLC boosted its stake in Davita by 3.3% during the second quarter. Meadow Creek Investment Management LLC now owns 88,416 shares of the company’s stock worth $4,974,000 after buying an additional 2,848 shares in the last quarter. Institutional investors and hedge funds own 91.47% of the company’s stock.
A number of equities research analysts have weighed in on DVA shares. Robert W. Baird downgraded shares of Davita from an “outperform” rating to a “neutral” rating and decreased their price target for the stock from $70.00 to $65.00 in a research note on Friday, July 26th. ValuEngine downgraded shares of Davita from a “hold” rating to a “sell” rating in a research note on Tuesday, August 20th. SunTrust Banks reiterated a “hold” rating and set a $68.00 price target on shares of Davita in a research note on Wednesday. UBS Group decreased their price target on shares of Davita from $61.00 to $60.00 and set a “neutral” rating on the stock in a research note on Thursday, August 22nd. Finally, William Blair downgraded shares of Davita from an “outperform” rating to a “market perform” rating in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and two have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $67.31.
Davita (NYSE:DVA) last posted its quarterly earnings results on Thursday, August 1st. The company reported $1.22 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.10 by $0.12. The firm had revenue of $2.84 billion for the quarter, compared to the consensus estimate of $2.86 billion. Davita had a net margin of 1.21% and a return on equity of 14.67%. The business’s revenue was down 1.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.05 earnings per share. As a group, research analysts forecast that Davita Inc will post 4.8 EPS for the current year.
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Further Reading: Limitations of the P/E Growth ratio
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.